Massachussetts is out to plant deals that could both create jobs and spark innovation in its biotech sector, and to underscore their ambitions, the state’s Governor joined the mayor of Boston and representatives of key trade bodies for a series of public and private meetings at the recent 15,000-strong Biotechnology Industry Organization (BIO) convention in Washington, DC.
One result was that IDBS Ltd, a UK-based software company specialising in the R&D and healthcare sectors, said it was to establish a US healthcare headquarters at its existing office in Burlington, MA, where it also is expanding its staff.
Also at BIO, Massachusetts announced R&D collaborations with Northern Ireland, Finland and Israel.
To read the full, original article click on this link: Science|Business - The media network for research, industry and policy
Author: Lori Valigra
